| 621/1507 | US=28 / Biol/Mol Siemann DW, Horsman MR. Small-molecule vascular disrupting agents in cancer therapy. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 297-310. ISBN 978-1-58829-870-6. |
| 622/1507 | US=23 / Câncer Bach-Gansmo T, Tobin D. Breast cancer: detection by in-vivo imaging of angiogenesis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 33-42. ISBN 978-1-4020-8368-6. CANCER DE MAMA; ANGIOGENESE IN VIVO; INTEGRINAS; CINTILOGRAFIA; TC-NC100692; EXPERIENCIA CLINICA INICIAL; RAIOS GAMA; CAMARA GAMA |
| 623/1507 | US=28 / Biol/Mol Mendoza E, Burd R, Wachsberger P, Dicker AP. Normalization of tumor vasculature and improvement of radiation response by antiangiogenic agents. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 311-21. ISBN 978-1-58829-870-6. ANGIOGENESE; AGENTES ANTI-ANGIOGENICOS; CANCER; CLINICO; PRE-CLINICO; NORMALIZACAO; TUMOR; RESPOSTA RADIACAO; TERAPIA DE RADIACAO; OXIGENACAO DO TUMOR; VASCULATURA |
| 624/1507 | US=28 / Biol/Mol Ellis LM, Dallas NA, Buren II GV, Lim S, Xia L, Fan F, Gray MJ. Challenges in translating antiangiogenic therapy from the bench to bedside. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 323-30. ISBN 978-1-58829-870-6. ANGIOGENESE; FARMACOCINETICA; DOSE MAXIMA TOLERADA; INTEGRIDADE; INVESTIGACAO TRANSLACIONAL |
| 625/1507 | US=28 / Biol/Mol Han L, Lorincz AM, Sukumar S. Regulation of angiogenesis in cancer and its therapeutic implications. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 331-49. ISBN 978-1-58829-870-6. |
| 626/1507 | US=23 / Câncer Mattie MD, Getts RC. Breast and prostate biopsies: use of optimized high-throughput microRNA expression for diagnosis (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 43-59. ISBN 978-1-4020-8368-6. CANCER DE MAMA. DIAGNOSTICO; BIOPSIAS; USO DE EXPRESSAO DE MICRORNA; METODOLOGIA |
| 627/1507 | US=28 / Biol/Mol DuBois S, Demetri G. Angiogenesis and angiogenesis inhibition in sarcomas. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 353-69. ISBN 978-1-58829-870-6. |
| 628/1507 | US=28 / Biol/Mol Grothey A. Antiangiogenesis agents in colorectal cancer. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 371-84. ISBN 978-1-58829-870-6. |
| 629/1507 | US=23 / Câncer Bult P, Hoogerbrugge N. Familial breast cancer: detection of prevalent high-risk epithelial lesions. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 61-71. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA FAMILIAR; CARCINOMA LOBULAR IN SITU; HIPERPLASIA LOBULAR ATIPICA; CARCINOMA DUCTAL IN SITU; HIPERPLASIA DUCTAL ATIPICA |
| 630/1507 | US=28 / Biol/Mol Warren KE, Fine HA. Antiangiogenic therapy for primary CNS tumors. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 385-408. ISBN 978-1-58829-870-6. GLIOMA; GLIOBLASTOMA; ASTROCITOMA; MEDULOBLASTOMA; QUIMIOTERAPIA; VASCULATURA |
| 631/1507 | US=28 / Biol/Mol Nilsson MB, Hanraban EO, Heymach JV. Angiogenesis inhibitors for the treatment of lung cancer. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 409-26. ISBN 978-1-58829-870-6. |
| 632/1507 | US=28 / Biol/Mol Gordon MS, Ebbinghaus SW. Antiangiogenic therapy of renal cell carcinoma. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 427-39. ISBN 978-1-58829-870-6. CARCINOMA DE CELULAS RENAIS; CANCER DE RIM; ANTI ANGIOGENICA; TERAPIA-ALVO |
| 633/1507 | US=28 / Biol/Mol Burger RA. Antiangiogenesis therapies in gynecologic malignancies. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 441-56. ISBN 978-1-58829-870-6. QUIMIOTERAPIA; GLIOMA; GLIOBLASTOMA; ASTROCITOMA; MEDULOBLASTOMA; VASCULATURA |
| 634/1507 | US=23 / Câncer Tang APY, Tse GMK, Lam WWM. Differentiation between benign and malignant papillary lesions of breast: excisional biopsy or stereotactic vacuum-assisted biopsy (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 73-97. ISBN 978-1-4020-8368-6. CANCER DE MAMA; LESOES BENIGNAS PAPILARES DE MAMA; LESOES MALIGNAS PAPILARES DE MAMA; BIOPSIA EXCISIONAL; BIOPSIA VACUO-ASSISTIDA; BIOPSIA ASSISTIDA POR VACUO; CARCINOMA DUCTAL; ASPIRACAO POR AGULHA FINA; BIOPSIA POR AGULHA; BIOPSIA EXCISIONAL; ESTEREOTAXIA; ULTRASSOM |
| 635/1507 | US=28 / Biol/Mol Melchert M, List AF. Antiangiogenic agents in myeloid malignancies. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 457-73. ISBN 978-1-58829-870-6. SINDROMES MIELODISPLASICAS; LEUCEMIA MIELOIDE AGUDA; LEUCEMIA MIELOIDE CRONICA; DOENCAS REUMATICAS; ANGIOGENESE; NEOVASCULARIZCAO; VEGF |
| 636/1507 | US=23 / Câncer Knauer M, Konstantiniuk P, Haid A, Wenzl E, Koberle-Wuhrer R, Riegler-Keil M, Postlberger S, Reitsamer R, Schrenk P. Multicentric breast cancer: sentinel node biopsy as a diagnostic tool. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 99-108. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA MULTICENTRICO; BIOPSIA DE LINFONODO SENTINELA |
| 637/1507 | US=23 / Câncer Lumachi F, Basso SMM, Basso U. Breast cancer recurrence: role of serum tumor markers CEA and CA 15-3. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 109-15. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA RECORRENTE; PAPEL DO SORO; MARCADORES TUMORAIS; CEA; CA 15-3; ANTIGENO CARCINOEMBRIONARIO |
| 638/1507 | US=23 / Câncer Zehentner BK. Breast cancer patients before, during or after treatment: circulating tumor cells in peripheral blood detected by multigene real-time reverse transcriptase-polymerase chain reaction. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 117-23. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CELULAS TUMORAIS CIRCULANTES; SANGUE PERIFERICO; REACAO MULTIGENICA EM TEMPO REAL; REACAO EM CADEIA DA POLIMERASE-TRANSCRIPTASE REVERSA |
| 639/1507 | US=28 / Urologia Mahadevan A. Role of radiation therapy in advanced renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 497-505. ISBN 978-1-58829-251-3. CARCINOMA DE CELULAS RENAIS AVANCADO. RADIOTERAPIA; PALIATIVO RADIOTERAPIA |
| 640/1507 | US=23 / Câncer Feng Q, Kiviat NB. Breast cancer patients: diagnostic epigenetic markers in blood. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 125-40. ISBN 978-1-4020-8368-6. CANCER DE MAMA. DIAGNOSTICO; MARCADORES EPIGENETICOS NO SANGUE; ANALISE DE METILACAO; METILACAO-ESPECIFICA PCR; METODO DE REACAO EM CADEIA POR POLIMERASE; ANALISE DE DADOS |